Jun 18, 2024 05:28PM
May 15, 2024 08:45AM
May 15, 2024 08:45AM
May 9, 2024 02:42PM
May 9, 2024 06:07AM
Apr 29, 2024 04:35PM
Apr 25, 2024 04:30PM Form S-1/A Inhibikase Therapeutics,
Apr 19, 2024 05:15PM
Dec 19, 2023 08:31AM
Apr 26, 2023 08:04AM
Apr 26, 2023 08:00AM
Feb 2, 2023 06:04AM
Mar 8, 2022 08:00AM
Jan 5, 2022 08:30AM Inhibikase Therapeutics Highlights 2022 Pipeline Goals and Milestones
Nov 29, 2021 08:05AM
Nov 15, 2021 05:30PM
Oct 27, 2021 08:05AM
Oct 19, 2021 08:05AM
Oct 4, 2021 08:05AM
Sep 23, 2021 08:08AM
Sep 23, 2021 08:05AM Inhibikase Therapeutics Receives Grant from U.S. National Institutes of Health to Evaluate IkT-148009 for the Treatment of Multiple System Atrophy
Sep 7, 2021 08:00AM
Aug 16, 2021 04:45PM
Jul 26, 2021 08:44AM
Jul 26, 2021 08:42AM
Jun 18, 2021 06:45PM
Jun 16, 2021 06:21AM
Jun 15, 2021 07:40PM Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
Jun 11, 2021 04:25PM
Feb 22, 2021 08:05AM
Feb 17, 2021 08:10AM
Feb 17, 2021 08:05AM
Jan 4, 2021 08:01AM
Dec 28, 2020 10:33AM
Dec 22, 2020 06:25PM Inhibikase Therapeutics, Inc. Announces Pricing of its Initial Public Offering
Nov 3, 2020 06:08AM
Oct 16, 2020 06:05AM
Sep 30, 2020 06:10AM
Sep 15, 2020 05:31PM

66,407 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All